Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 386 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Anónimo. Inzitan® (dexametasona, tiamina, cianocobalamina, lidocaína): suspensión de comercialización. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2017:30 de noviembre. [Ref.ID 102154]
2. Cita con resumen
Patel P, Leeder JS, Piquette-Miller M, Dupuis LL. Aprepitant and fosaprepitant drug interactions: a systematic review. Br J Clin Pharmacol 2017;83:2148-62. [Ref.ID 102081]
3. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
4. Cita con resumen
Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol Drug Saf 2017;26:635-41. [Ref.ID 101626]
5. Cita con resumen
7.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
9. Cita con resumen
Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KSS, Fang Y, Huang X-P, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate Jr CA, Gould TD. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016;533:481-6. [Ref.ID 100336]
10. Cita con resumen
Taylor P, Nutt D, Fortson R, Henderson G, on behalf of DrugScience. Ketamine—the real perspective. Lancet 2016;387:1271-2. [Ref.ID 100277]
11. Cita con resumen
Healy D. Serotonin and depression. BMJ 2015;350:h1771. [Ref.ID 98976]
12. Cita con resumen
Anónimo. Prilocaïne intrathécale. Prescrire 2015;35:9-10. [Ref.ID 98897]
13. Cita con resumen
Patorno E, Neuman MD, Schneeweiss S, Mogun H, Bateman BT. Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study. BMJ 2014;349:g4022. [Ref.ID 98063]
16. Cita con resumen
Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014;370:444-54. [Ref.ID 97065]
17.
Fernández S, Castro P, Nogué S, Nicolás JM. Orina verde secundaria a propofol. Med Clin (Barc) 2013;141:463. [Ref.ID 96513]
18. Cita con resumen
Hosseinjani H, Moghaddas A, Khalili H. N-acetylcysteine for the prevention of non-constrast media agent-induced kidney injury: from preclinical data to clinical evidence. Eur J Clin Pharmacol 2013;69:1375-90. [Ref.ID 95850]
20.Tiene citas relacionadas Cita con resumen
Chowdhary S, Bukoye B, Bhansali AM, Carbo AR, Adra M, Barnett S, Aronson MD, Leffler DA. Risk of topical anesthetic-induced methemoglobinemia: a 10-year retrospective case-control study. JAMA Intern Med 2013;173:771-6. [Ref.ID 95424]
Seleccionar todas
 
 1 a 20 de 386 siguiente >>